Royal Philips Electronics Creates Public-Private Partnership in Germany to Develop Advances in MPI Systems

German government and private industry partners will to invest a total of just over $27M US to the Consortium
Magnetic particle imaging (MPI) relies on the magnetic properties of iron-oxide nanoparticles which are injected into the bloodstream. An MPI system detects the nanoparticles to produce 3D images of physiological processes. The technology has gone so far as to successfully capture real-time, 3D images of blood flow and heart activity in mice. Philips and the University of Lübeck will work on the development of whole-body MPI demonstrators. Additional partners in the Consortium include Bruker, Bayer-Schering Pharma, and the Physikalisch-Technische Bundesanstalt.

↑ Back to TechConnect News™

Event Spotlights

Austin, TX, December 1-3, 2015
Austin, TX, December 1-3, 2015

Annual Meeting

TechConnect World 2015
Washington, DC, May 22-25, 2016